NOVOCART®3D for Treatment of Articular Cartilage of the Knee

Not Recruiting

Trial ID: NCT01957722

Purpose

This study is to compare NOVOCART 3D relative to Microfracture for the treatment of knee cartilage defects. Efficacy will be evaluated by both pain and function. Safety will also be evaluated.

Official Title

A Phase 3, Prospective, Randomized, Partially Blinded Multi-Center Study to Measure the Safety and Efficacy of NOVOCART 3D Compared ot Microfracture in the Treatment of Articular Cartilage Defects

Stanford Investigator(s)

Seth Sherman
Seth Sherman

Associate Professor of Orthopaedic Surgery

Eligibility

Inclusion Criteria:

* Greater than 18 years old
* Isolated articular cartilage lesions on the femoral condyle 2-6 cm2
* Minimum score on the KOOS questionnaire

Exclusion Criteria:

* Instability of the knee joint
* Arthritis
* Autoimmune disease
* Immune suppression
* Prior surgical treatment using mosaicplasty, autologous chondrocyte implantation and/or microfracture (debridement and lavage are acceptable beyond three months from baseline)
* Bone disease
* Any degenerative muscular, connective tissue or neurological condition or other disease process that would interfere with healing or the evaluation of outcome measures.

Intervention(s):

procedure: Microfracture

biological: NOVOCART 3D

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305

Stanford Medicine

Redwood, California 94063